The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia.

Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0931-041X (Print) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE

Publication: Berlin : Springer International
Original Publication: Berlin : Springer International, c1987-

Mutation*; Carrier Proteins/*genetics ; Kidney Diseases/*genetics ; Kidney Diseases/*urine ; Metabolic Diseases/*genetics ; Metabolic Diseases/*urine ; Organic Anion Transporters/*genetics ; Uric Acid/*urine; Adolescent ; Adult ; Child ; Child, Preschool ; Exons/genetics ; Female ; Humans ; Introns/genetics ; Japan ; Male ; Organic Cation Transport Proteins ; Sequence Analysis, DNA

Recently, a urate transporter, hURAT1 (human uric acid transporter 1) encoded by SLC22A12, was isolated from the human kidney. hURAT1 is presumed to play the central role in reabsorption of urate from glomerular filtrate. In the present study, we analyzed SLC22A12 in seven unrelated Japanese patients with renal hypouricemia whose serum level of urate was less than 1.0 mg/dl, and their family members. We performed direct DNA sequencing of the exon and exon-intron boundaries of SLC22A12 using genomic DNA. Six of the seven patients (86%) possess mutations in SLC22A12. In five patients, a homozygous G to A transition at nucleotide 774 within exon 4 of SLC22A12, which forms a stop codon (TGA) at codon 258 (TGG), was identified (W258X). In one patient, the C to T transition within exon 3, which changes threonine at codon 217 to methionine (T217 M), and the W258X mutation were found (compound heterozygote). Thus, among 12 mutational alleles in six patients, 11 were the W258 X mutation (92%). Family members with the heterozygous W258X mutation (carriers) show relatively low levels of serum urate. The present study demonstrates that homozygous W258X mutation is the predominant genetic cause of idiopathic renal hypouricemia in Japanese patients.

Physiol Rev. 1993 Oct;73(4):765-96. (PMID: 8415925)
Klin Wochenschr. 1989 Mar 1;67(5):308-12. (PMID: 2709741)
Scanning Microsc. 1993 Mar;7(1):417-21. (PMID: 8316811)
Miner Electrolyte Metab. 1994;20(6):424-31. (PMID: 7783706)
Pflugers Arch. 2000 Jul;440(3):337-50. (PMID: 10954321)
Contrib Nephrol. 1992;100:1-14. (PMID: 1458896)
Nature. 2002 May 23;417(6887):447-52. (PMID: 12024214)
Clin Nephrol. 1995 Mar;43(3):207-8. (PMID: 7774083)
Am J Kidney Dis. 1998 Dec;32(6):917-33. (PMID: 9856507)
Annu Rev Physiol. 2002;64:563-94. (PMID: 11826280)
Am J Kidney Dis. 1995 Jun;25(6):937-46. (PMID: 7771493)
News Physiol Sci. 1999 Apr;14:80-84. (PMID: 11390825)
Pediatr Nephrol. 1993 Jun;7(3):292-3. (PMID: 8518102)
Nephron. 2002 Aug;91(4):559-70. (PMID: 12138255)
J Pharmacol Exp Ther. 1997 Feb;280(2):839-45. (PMID: 9023298)
J Clin Invest. 2001 May;107(9):1103-15. (PMID: 11342574)
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9412-6. (PMID: 2594778)
Nephron. 1994;66(4):475-6. (PMID: 8015655)
Nephron. 1989;51(1):13-6. (PMID: 2915747)
Am J Physiol Renal Physiol. 2002 Jul;283(1):F150-63. (PMID: 12060597)
J Mol Evol. 1992 Jan;34(1):78-84. (PMID: 1556746)

0 (Carrier Proteins)
0 (Organic Anion Transporters)
0 (Organic Cation Transport Proteins)
0 (SLC22A12 protein, human)
268B43MJ25 (Uric Acid)

Date Created: 20040401 Date Completed: 20050308 Latest Revision: 20181113

20250114

10.1007/s00467-004-1424-1

15054642